A TEACH-BACK APPROACH TO INCREASE BREAST CANCER KNOWLEDGE IN WOMEN WITH LOW HEALTH LITERACY: AN INTERVENTION STUDY (Teach-Back Met)

August 17, 2026 updated by: HURİ YOĞURTCU, Buca Seyfi Demirsoy State Hospital

Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy.

Method: This research is a randomized controlled experimental study. The study is planned to be conducted with individuals who applied to the KETEM unit of Healthy Life Center No. 1, affiliated with the Karabağlar District Health Directorate in İzmir.

Data will be evaluated for normality; dependent samples t-test will be used for pre- and post-education comparisons, and Wilcoxon signed-rank test will be used if normality is not achieved. Baseline differences between the experimental and control groups will be analyzed with independent samples t-test or Mann-Whitney U test, and categorical variables will be analyzed with the Chi-square test. In the study, the experimental group will receive breast cancer education in groups of 5, consisting of 20-minute sessions with a 4-week interval, presented in simple language avoiding medical jargon, and the education content will be re-explained by the participants in their own words. These sessions will consist of general content such as breast cancer risk factors, symptoms, and the importance of early diagnosis.

  1. What are the risk factors and symptoms of breast cancer?
  2. The importance of early detection of breast cancer (BSE, clinical breast examination (CBE), mammography).
  3. What are the treatment options for breast cancer? (Surgical methods, systemic treatments (endocrine therapy, chemotherapy, hormonal therapy), and radiotherapy) (Kiyat & Akyüz, 2024; Uçkaç, 2022; Altu et al., 2023; Hosseinifar, Afkhamzadeh & Moayeri, 2024).

The control group will be educated using existing educational materials used by the Ministry of Health. The content of these trainings will consist of topics such as breast cancer risk factors, symptoms, and the importance of early diagnosis. The Teach Back technique will not be applied to the control group.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy.

Method: This research is a randomized controlled experimental study. The study is planned to be conducted with individuals who applied to the KETEM unit of Healthy Life Center No. 1, affiliated with the Karabağlar District Health Directorate in İzmir.

Data will be evaluated for normality; dependent samples t-test will be used for pre- and post-education comparisons, and Wilcoxon signed-rank test will be used if normality is not achieved. Baseline differences between the experimental and control groups will be analyzed with independent samples t-test or Mann-Whitney U test, and categorical variables will be analyzed with the Chi-square test. In the study, the experimental group will receive breast cancer education in groups of 5, consisting of 20-minute sessions with a 4-week interval, presented in simple language avoiding medical jargon, and the education content will be re-explained by the participants in their own words. These sessions will consist of general content such as breast cancer risk factors, symptoms, and the importance of early diagnosis.

  1. What are the risk factors and symptoms of breast cancer?
  2. The importance of early detection of breast cancer (BSE, clinical breast examination (CBE), mammography).
  3. What are the treatment options for breast cancer? (Surgical methods, systemic treatments (endocrine therapy, chemotherapy, hormonal therapy), and radiotherapy) (Kiyat & Akyüz, 2024; Uçkaç, 2022; Altu et al., 2023; Hosseinifar, Afkhamzadeh & Moayeri, 2024).

The control group will be educated using existing educational materials used by the Ministry of Health. The content of these trainings will consist of topics such as breast cancer risk factors, symptoms, and the importance of early diagnosis. The Teach Back technique will not be applied to the control group.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Women over 18 years of age,

    • Having a health literacy score below 25 on the Turkish Health Literacy Scale.
    • Not having a diagnosed mental, visual, or learning disability by a physician.
    • Not having previously participated in any research project on breast health/breast education.
    • Being able to communicate verbally.
    • Not having breast cancer.

Exclusion Criteria:

  • • Having a previous diagnosis of breast cancer. • Having cognitive impairments that may prevent participation in the study. • Having hearing or visual impairments that may negatively affect participation and interaction in the training process. • Lack of sufficient language proficiency to understand the training materials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Participants receive structured individual breast cancer awareness and screening education delivered using the Teach-Back method.
Structured individual health education on breast cancer screening and awareness delivered using the Teach-Back method to ensure comprehension among participants with low health literacy.
Other Names:
  • Teach-Back Method Education
  • Standard Care Education
No Intervention: Control Group
Participants receive standard breast cancer awareness and screening education provided through routine health center procedures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Breast Cancer Knowledge Level
Time Frame: Baseline (pre-intervention) and 1 month post-intervention
Assessed using the Knowledge Scale for Breast Cancer and Screening Methods (GKMKBT). Total scores range from 0 to 44, with higher scores indicating greater knowledge regarding breast cancer and screening procedures.
Baseline (pre-intervention) and 1 month post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health Literacy Level
Time Frame: Baseline (pre-intervention) and 1 month post-intervention
Assessed using the Turkey Health Literacy Scale-32 (TSOY-32). Scores range from 0 to 50, where higher scores represent higher health literacy levels.
Baseline (pre-intervention) and 1 month post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

August 17, 2026

First Submitted That Met QC Criteria

August 17, 2026

First Posted (Actual)

August 20, 2026

Study Record Updates

Last Update Posted (Actual)

August 20, 2026

Last Update Submitted That Met QC Criteria

August 17, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared to protect participant privacy and maintain confidentiality, as explicit consent for secondary data sharing was not obtained from participants under the approved study protocol.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe